UnitedHealth Group has remained a subject of active institutional attention heading into mid-2026. The company operates across managed care, pharmacy benefits, and health services segments, and has drawn continued scrutiny amid a broader environment of elevated healthcare costs and ongoing regulatory developments. Multiple briefings issued between 1 June and 17 June 2026 noted that institutional interest in UNH persisted across this period, reflecting sustained engagement with the stock by large investment managers [Brief - 2026-06-17] [Brief - 2026-06-09] [Brief - 2026-06-01].
As of 31 March 2026, UnitedHealth Group reported trailing twelve-month revenue of approximately $449.7 billion, representing year-over-year growth of 1.96%. Net income on a TTM basis stood at $12.8 billion, with a net margin of 2.85% and an operating margin of 4.19%. EPS growth on a year-over-year basis was 0.73%. The company held $28.0 billion in cash against total debt of $77.9 billion. The market capitalisation was approximately $368.5 billion, and the P/E ratio was recorded at 30.56 [SEC 10-Q - UNH - 2026-03-31].
Insider activity in June 2026 comprised three transactions with a mixed net direction and a net value of zero, indicating no material net change in insider-held positions during the period [SEC Form 4 - UNH - 2026-06]. At the institutional level, Millennium Management added 56% to its UNH position, while AQR Capital increased its holding by 36% and Soros Fund Management added 14%. Conversely, Citadel reduced its position by 19% and Tiger Global decreased its holding by 17% [SEC 13F - Millennium - Q1 2026] [SEC 13F - AQR Capital - Q1 2026] [SEC 13F - Soros Fund Mgmt - Q1 2026] [SEC 13F - Citadel - Q1 2026] [SEC 13F - Tiger Global - Q1 2026].
The prevailing macro environment as of the report date showed the 10-year US Treasury yield at 4.50% and the 2-year yield at 4.16%, producing a normal yield curve with a spread of 34 basis points [FRED DGS10] [FRED DGS2]. This report was generated in response to material institutional position changes observed across multiple large investment managers during the most recent 13F reporting period.